Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01879397 · ClinicalTrials.gov registry record

Pilot Study of Ultrasonic Determined Carotid Plaque Composition

A clinical trial of Atherosclerosis, sponsored by D. Geoffrey Vince.

Completed
Registry status
150
Enrollment target
1
Study location

NCT01879397: Completed study of Atherosclerosis, sponsored by D. Geoffrey Vince.

NCT01879397 is a study of Atherosclerosis that has completed, run by D. Geoffrey Vince. The registered enrollment target is 150 participants, below the 1,064-participant average among 69 other Atherosclerosis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01879397, a study of Atherosclerosis, has completed, sponsored by D. Geoffrey Vince.

COMPLETED
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

Pilot prospective two group observational study to create a model of the carotid plaque composition based on ultrasonic backscattered signals and select clinical data.

Primary Outcome

Classification of carotid artery plaque is produced by an algorithm that uses the QUS and ARFI derived parameters corresponding to a given region in the plaque to produce a classification of the plaque region into one of the following: calcium, fibrous, necrotic, or hemorrhagic. Error rates from both the training and test data sets will be reported.

Conditions Studied

Interventions

  • DEVICE Research Ultrasound Exam

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2013-05
Est. Completion 2020-02-27
D. Geoffrey Vince

1 total trials

What the finished NCT01879397 record still lists

NCT01879397 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,064-participant average among 69 other Atherosclerosis trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Atherosclerosis appearing as the primary indexed condition, and to 1 intervention - of which Research Ultrasound Exam is the first listed.

NCT01879397 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01879397 about?

NCT01879397 is a clinical study titled "Pilot Study of Ultrasonic Determined Carotid Plaque Composition". Pilot prospective two group observational study to create a model of the carotid plaque composition based on ultrasonic backscattered signals and select clinical data.

What is the current status of trial NCT01879397?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2013-05. Estimated completion is 2020-02-27.

What conditions does trial NCT01879397 study?

This clinical trial studies the following conditions: Atherosclerosis.

What interventions are being tested in trial NCT01879397?

The interventions under investigation include: Research Ultrasound Exam (DEVICE).

Who is sponsoring clinical trial NCT01879397?

This trial is sponsored by D. Geoffrey Vince, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01879397 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atherosclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01879397's enrollment target sits among peer trials

150 43rd of 69 higher than 27 of 69 other Atherosclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Atherosclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01879397, the US trial registry maintained by the National Library of Medicine. NCT01879397 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.